During the past decade, Studienzentrum Nord-West conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
A Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose Levels of TAK-831 in Adjunctive Treatment of Adult Participants With Negative Symptoms of Schizophrenia
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
2020-11-20
2024-02-15
Recruiting
431
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Studienzentrum Nord-West" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Alzheon Inc." with 1 trials
sponsored, "AstraZeneca" with 1 trials sponsored, "Avraham Pharmaceuticals Ltd" with 1 trials sponsored and "H. Lundbeck A/S"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Nord-West"
#1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Studienzentrum Nord-West
According to Clinical.Site data, the most researched conditions in "Studienzentrum Nord-West" are
"Schizophrenia" (2 trials), "Alzheimer´s Disease" (1 trials), "Binge Eating Disorder" (1 trials), "Clostridium Difficile Infection" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Studienzentrum Nord-West" in a lesser frequency.
Clinical Trials Intervention Types at Studienzentrum Nord-West
Most popular intervention types in "Studienzentrum Nord-West" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "400mg LM11A-31-BHS" (1 trials), "800mg LM11A-31-BHS" (1 trials), "BI 1358894" (1 trials) and "BI 425809" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Studienzentrum Nord-West
The vast majority of trials in "Studienzentrum Nord-West" are
10 trials for "All" genders.
Clinical Trials Status at Studienzentrum Nord-West
Currently, there are NaN active trials in "Studienzentrum Nord-West".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Studienzentrum Nord-West,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Studienzentrum Nord-West, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".